2023 Q1 Form 10-K Financial Statement

#000141057823000263 Filed on March 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $77.20M $47.44M $325.2M
YoY Change -8.46% 25.6% 68.73%
Cost Of Revenue $46.87M $32.11M $162.3M
YoY Change 21.68% 54.7% 34.07%
Gross Profit $30.33M $15.34M $162.9M
YoY Change -33.81% -9.89% 127.3%
Gross Profit Margin 39.29% 32.33% 50.09%
Selling, General & Admin $6.977M $7.534M $28.59M
YoY Change 2.24% 7.94% 7.62%
% of Gross Profit 23.0% 49.12% 17.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $751.0K $698.0K $3.184M
YoY Change -19.85% -54.82% -5.99%
% of Gross Profit 2.48% 4.55% 1.95%
Operating Expenses $7.675M $8.232M $31.38M
YoY Change 2.03% 7.22% 6.9%
Operating Profit $22.66M $7.105M $131.5M
YoY Change -40.85% -23.95% 210.86%
Interest Expense $1.849M -$2.034M $14.33M
YoY Change -74.69% -28.48% 25.94%
% of Operating Profit 8.16% -28.63% 10.89%
Other Income/Expense, Net $0.00 -$14.33M
YoY Change -100.0% 47656.67%
Pretax Income $20.81M $5.071M $117.2M
YoY Change -32.87% -21.96% 250.9%
Income Tax $5.275M -$9.000K $13.38M
% Of Pretax Income 25.35% -0.18% 11.42%
Net Earnings $15.53M $5.080M $103.8M
YoY Change -47.45% -17.91% 221.77%
Net Earnings / Revenue 20.12% 10.71% 31.92%
Basic Earnings Per Share $0.34 $2.31
Diluted Earnings Per Share $0.33 $0.11 $2.20
COMMON SHARES
Basic Shares Outstanding 45.33M 44.99M
Diluted Shares Outstanding 47.31M 47.11M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.32M $5.295M $5.295M
YoY Change 139.17% 51.63% 51.63%
Cash & Equivalents $12.32M $5.295M $5.295M
Short-Term Investments
Other Short-Term Assets $6.726M $5.289M $5.289M
YoY Change -12.42% -34.62% -34.62%
Inventory $137.0M $145.4M $145.4M
Prepaid Expenses
Receivables $38.76M $20.87M $20.87M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $194.8M $176.8M $176.8M
YoY Change 27.9% 47.42% 47.42%
LONG-TERM ASSETS
Property, Plant & Equipment $20.23M $20.57M $27.91M
YoY Change 5.45% 2.36% 3.76%
Goodwill $47.80M $47.80M
YoY Change 0.0% 0.0%
Intangibles $16.87M $17.56M
YoY Change -14.21% -13.72%
Long-Term Investments
YoY Change
Other Assets $2.387M $2.386M $2.386M
YoY Change 238.58% 236.06% 236.06%
Total Long-Term Assets $95.00M $95.66M $95.66M
YoY Change 0.51% -0.11% -0.11%
TOTAL ASSETS
Total Short-Term Assets $194.8M $176.8M $176.8M
Total Long-Term Assets $95.00M $95.66M $95.66M
Total Assets $289.8M $272.5M $272.5M
YoY Change 17.41% 26.32% 26.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.16M $14.17M $14.17M
YoY Change 75.76% 47.2% 47.2%
Accrued Expenses $35.32M $11.70M $34.21M
YoY Change 3.91% -16.37% -1.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $4.250M $4.250M $4.250M
YoY Change 0.0% -19.02% -19.02%
Total Short-Term Liabilities $54.72M $52.63M $52.63M
YoY Change 16.78% -18.33% -18.33%
LONG-TERM LIABILITIES
Long-Term Debt $35.93M $38.99M $38.99M
YoY Change -60.74% -46.7% -46.7%
Other Long-Term Liabilities $6.062M $5.763M $5.763M
YoY Change 4.18% 4.78% 4.78%
Total Long-Term Liabilities $35.93M $38.99M $44.75M
YoY Change -60.74% -46.7% -43.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.72M $52.63M $52.63M
Total Long-Term Liabilities $35.93M $38.99M $44.75M
Total Liabilities $98.32M $97.62M $97.62M
YoY Change -32.63% -32.57% -32.57%
SHAREHOLDERS EQUITY
Retained Earnings $73.51M $57.98M
YoY Change -551.93% -226.54%
Common Stock $453.0K $453.0K
YoY Change 0.89% 1.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $191.5M $174.9M $174.9M
YoY Change
Total Liabilities & Shareholders Equity $289.8M $272.5M $272.5M
YoY Change 17.41% 26.32% 26.32%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $15.53M $5.080M $103.8M
YoY Change -47.45% -17.91% 221.77%
Depreciation, Depletion And Amortization $751.0K $698.0K $3.184M
YoY Change -19.85% -54.82% -5.99%
Cash From Operating Activities $10.67M $2.799M $62.82M
YoY Change 110.54% -130.25% -5215.23%
INVESTING ACTIVITIES
Capital Expenditures $412.0K $1.944M $3.659M
YoY Change 1425.93% -254.65% 90.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$412.0K -$1.944M -$3.659M
YoY Change 1425.93% 54.65% 90.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $182.0K
YoY Change -9.45%
Debt Paid & Issued, Net $3.263M $148.1M
YoY Change -95.91% 2719.0%
Cash From Financing Activities -3.227M -10.61M -57.35M
YoY Change -4.5% -335.86% -1183.36%
NET CHANGE
Cash From Operating Activities 10.67M 2.799M 62.82M
Cash From Investing Activities -412.0K -1.944M -3.659M
Cash From Financing Activities -3.227M -10.61M -57.35M
Net Change In Cash 7.027M -9.754M 1.803M
YoY Change 323.31% 62.27% -15.9%
FREE CASH FLOW
Cash From Operating Activities $10.67M $2.799M $62.82M
Capital Expenditures $412.0K $1.944M $3.659M
Free Cash Flow $10.25M $855.0K $59.16M
YoY Change 103.49% -110.69% -1977.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000925528
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022 dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45287619
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44758925
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P6M
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
1-13412
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
CY2022 dei City Area Code
CityAreaCode
845
CY2022 dei Local Phone Number
LocalPhoneNumber
735-6000
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2022 dei Trading Symbol
TradingSymbol
HDSN
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
323382755
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45328892
CY2022 dei Auditor Firm
AuditorFirmId
243
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
Stamford
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5295000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3492000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20872000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14223000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5289000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8090000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176833000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
119949000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2022Q4 us-gaap Goodwill
Goodwill
47803000
CY2021Q4 us-gaap Goodwill
Goodwill
47803000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17564000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20357000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7339000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6803000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2386000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
710000
CY2022Q4 us-gaap Assets
Assets
272493000
CY2021Q4 us-gaap Assets
Assets
215715000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14165000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9623000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27908000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30637000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6303000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3931000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5248000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
15000000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52626000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64439000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1692000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5763000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q4 us-gaap Liabilities
Liabilities
97618000
CY2021Q4 us-gaap Liabilities
Liabilities
144776000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45287619
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44758925
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
453000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
448000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116442000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116312000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57980000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45821000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272493000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215715000
CY2022 us-gaap Revenues
Revenues
325225000
CY2021 us-gaap Revenues
Revenues
192748000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
162332000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
121084000
CY2022 us-gaap Gross Profit
GrossProfit
162893000
CY2021 us-gaap Gross Profit
GrossProfit
71664000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28591000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26566000
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2793000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2793000
CY2022 us-gaap Operating Expenses
OperatingExpenses
31384000
CY2021 us-gaap Operating Expenses
OperatingExpenses
29359000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
131509000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
42305000
CY2022 us-gaap Interest Expense
InterestExpense
14327000
CY2021 us-gaap Interest Expense
InterestExpense
11376000
CY2021 us-gaap Other Income
OtherIncome
2470000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14327000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8906000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
117182000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33399000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13381000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1140000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
103801000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.31
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.20
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44990104
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43765443
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47109018
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46640822
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
201000
CY2021 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
2655000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
511000
CY2021 us-gaap Profit Loss
ProfitLoss
32259000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
182000
CY2022 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
969000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
922000
CY2022 us-gaap Profit Loss
ProfitLoss
103801000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
103801000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3184000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3387000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2793000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2793000
CY2021 hdsn Payment Protection Program Forgiveness
PaymentProtectionProgramForgiveness
-2475000
CY2022 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
1837000
CY2021 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-2806000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
474000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1086000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1125000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
922000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
511000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1449000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
337000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7123000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4461000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
53070000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46878000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1782000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2120000
CY2022 hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
17000
CY2021 hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
4000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-630000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
674000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4526000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16378000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62815000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1228000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3659000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1922000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3659000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1922000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
182000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201000
CY2022 hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-969000
CY2021 hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-2655000
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
8512000
CY2021 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
13000000
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
148054000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5252000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57353000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5294000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1803000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2144000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
11702000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10157000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15460000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
128000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
CY2022 hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
CY2022 hdsn Allocation Allowance Received
AllocationAllowanceReceived
3000000
CY2022 hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2022, there was no customer accounting for greater than 10% of the Company’s revenues, but one customer accounted for over 10% of outstanding receivables at December 31, 2022. For the year ended December 31, 2021, one customer accounted for 10% of the Company’s revenues and one customer accounted for over 10% of the outstanding accounts receivable at December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
13600000
CY2021Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
12300000
CY2016Q3 hdsn Contract Term
ContractTerm
P5Y
CY2016Q3 hdsn Renewal Term
RenewalTerm
P5Y
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
325225000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
192748000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57405000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53854000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36837000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33761000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2022 us-gaap Depreciation
Depreciation
3200000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
103801000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44990104
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43765443
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2118914
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2875379
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47109018
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46640822
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28467
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2583523
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used including potential impact of COVID-19 uncertainties. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2021 us-gaap Depreciation
Depreciation
3400000
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1900000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1600000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1584000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
474000
CY2022 hdsn Allowance For Doubtful Accounts Receivable Deductions And Other
AllowanceForDoubtfulAccountsReceivableDeductionsAndOther
-131000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1927000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1597000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000
CY2021 hdsn Allowance For Doubtful Accounts Receivable Deductions And Other
AllowanceForDoubtfulAccountsReceivableDeductionsAndOther
-57000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1584000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
152840000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
99828000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
7463000
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
5684000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1867000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2106000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1384000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1284000
CY2022Q4 hdsn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2178000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8819000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1393000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7426000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1663000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1382000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5763000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7426000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6882000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y29D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0821
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0822
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
2600000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3100000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
117200000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33400000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13400000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11995000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
453000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2835000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
350000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14830000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
803000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-323000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
267000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1126000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
70000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1449000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
337000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13381000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1140000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.04
CY2022 hdsn Effective Income Tax Rate Reconciliation Nondeductible Expense Internal Revenue Code Act Limitation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInternalRevenueCodeActLimitationPercent
0.01
CY2021 hdsn Effective Income Tax Rate Reconciliation Nondeductible Expense Internal Revenue Code Act Limitation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInternalRevenueCodeActLimitationPercent
0
CY2022 hdsn Effective Income Tax Rate Reconciliation Paycheck Protection Program Ppp Benefit Percent
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramPppBenefitPercent
0
CY2021 hdsn Effective Income Tax Rate Reconciliation Paycheck Protection Program Ppp Benefit Percent
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramPppBenefitPercent
-0.02
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.13
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.12
CY2022 hdsn Effective Income Tax Rate Reconciliation Nondeductible Expense Other True Up Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOtherTrueUpPercent
-0.01
CY2021 hdsn Effective Income Tax Rate Reconciliation Nondeductible Expense Other True Up Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOtherTrueUpPercent
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.11
CY2022Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation And Amortization
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciationAndAmortization
-4916000
CY2021Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation And Amortization
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciationAndAmortization
-6365000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
500000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
398000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1045000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
977000
CY2022Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Non Qualified Stock Options
DeferredTaxAssetsTaxDeferredExpenseReservesAndNonQualifiedStockOptions
383000
CY2021Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Non Qualified Stock Options
DeferredTaxAssetsTaxDeferredExpenseReservesAndNonQualifiedStockOptions
612000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7270000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2637000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10381000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
107000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
184000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15149000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
244000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1692000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Goodwill
Goodwill
47800000
CY2022Q4 us-gaap Goodwill
Goodwill
47800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15433000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17564000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33397000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13040000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20357000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2700000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2700000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3900000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11696000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13986000
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
13638000
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
12307000
CY2022Q4 hdsn Lease Obligations Current
LeaseObligationsCurrent
1669000
CY2021Q4 hdsn Lease Obligations Current
LeaseObligationsCurrent
1378000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
905000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2966000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27908000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30637000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15000000
CY2022Q4 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2021Q4 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
5248000
CY2022Q4 us-gaap Debt Current
DebtCurrent
4250000
CY2021Q4 us-gaap Debt Current
DebtCurrent
20248000
CY2022Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
27563000
CY2021Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
74618000
CY2022Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3578000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1473000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
43235000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
93393000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
4250000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4250000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
4250000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4250000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
29813000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
46813000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3100000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4845343
CY2022 hdsn Share Based Compensation Arrangement By Share Based Payment Award Percentage From Fair Market Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageFromFairMarketPrice
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
381181
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2218799
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y4M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.33
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2583523
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8900000
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
CY2021Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2022 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
1249506
CY2021 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
1481858
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4051422
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7088578
CY2021 us-gaap Other Income
OtherIncome
2500000

Files In Submission

Name View Source Status
hdsn-20221231_cal.xml Edgar Link unprocessable
hdsn-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001410578-23-000263-index-headers.html Edgar Link pending
0001410578-23-000263-index.html Edgar Link pending
0001410578-23-000263.txt Edgar Link pending
0001410578-23-000263-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hdsn-20221231.xsd Edgar Link pending
hdsn-20221231x10k.htm Edgar Link pending
hdsn-20221231xex21.htm Edgar Link pending
hdsn-20221231xex23d1.htm Edgar Link pending
hdsn-20221231xex31d1.htm Edgar Link pending
hdsn-20221231xex31d2.htm Edgar Link pending
hdsn-20221231xex32d1.htm Edgar Link pending
hdsn-20221231xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
hdsn-20221231_pre.xml Edgar Link unprocessable
hdsn-20221231_lab.xml Edgar Link unprocessable
hdsn-20221231x10k_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending